Chinese Diagnostics Market Grows Steadily
Chinese Diagnostics Market Grows Steadily
Attachment: 04110001, A
BEIJING--April 12, 2022--Researched by Industrial Info Resources (Sugar Land, Texas)--China's in vitro diagnostics (IVD) market revenue reached CNY124.3 billion (US$19.52 billion) in 2021, according to www.askci.com. The molecular diagnosis sector has grown strongly due to the COVID-19 pandemic, and the point-of-care testing (POCT) market has grown steadily for the past few years.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- U.S. Supplement Production Brings Millions in Spending
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips